UNII 4J9FJ0HL51

POTASSIUM PHOSPHATE, MONOBASIC

Unique Ingredient Identifier 4J9FJ0HL51 is listed as a ingredient substance
RN7778-77-0
EC231-913-4
NCITC61900
RXCUI55019
MFK.H2O4P
INCHI KEYGNSKLFRGEWLPPA-UHFFFAOYSA-M
SMILES[K+].OP(O)([O-])=O

Alternate Names

Dosage Forms

UNII 4J9FJ0HL51 POTASSIUM PHOSPHATE, MONOBASIC is commonly included in medications in the following forms.

RouteDosage FormPotency
AN,INFILTRATIONINJECTION2.72 %
AURICULAR (OTIC)SOLUTION0.2 %
IM - IVINJECTION0.096 %
INTRA-ARTICULARINJECTION0.3 %
INTRAMUSCULARINJECTABLE0.096 %W/V
INTRAMUSCULARINJECTION0.3 %W/V
INTRAUTERINESOLUTION NA
INTRAVENOUSINJECTABLE0.096 %
INTRAVENOUSINJECTION68 MG/VIAL
INTRAVENOUSINJECTION0.68 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED68 MG/VIAL
INTRAVENOUSPOWDER, FOR RECONSTITUTION2.72 %
INTRAVENOUSSOLUTION, INJECTION0.085 %
INTRAVESICALSOLUTION, INJECTION2.92 %
IV(INFUSION)INJECTION68 MG/1VIAL
IV(INFUSION)SOLUTION, INJECTION1.36 %
NASALSOLUTION0.071 %
NASALSPRAY0.14 %
NERVE BLOCKINJECTION2.72 %
OPHTHALMICSOLUTION0.2 %
OPHTHALMICSUSPENSION0.44 %
ORALCAPSULE, ENTERIC COATED PELLETS17 MG
ORALEMULSION NA
ORALSOLUTION25 MG/5ML
ORALSOLUTION, SYRUP4.75 MG/1ML
ORALSUSPENSION50 MG/5ML
ORALSYRUP13.66 MG/5ML
ORALTABLET25 MG
ORALTABLET, SUSTAINED ACTION4 MG
SUBCUTANEOUSINJECTABLE0.27 %
SUBCUTANEOUSINJECTION0.27 %
SUBCUTANEOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED0.12 %

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.